The Role of a Clinical Pharmacist in the Management of Type 2 Diabetic Patients in a Primary Medical Center in Jordan

NCT06029842 | Completed DMC

• 1 other identifier: Clinical pharmacist
• Study Type: interventional
• Target: 103
• Locations: 1 country
• Sites: 1

Brief Summary

This study aimed to assess the impact of the clinical pharmacist on enhancing type 2 diabetic patients outcomes in a primary health care center.

Conditions

Pharmacist-Patient Relations

Keywords

clinical pharmacist; medical center; Ministry of Health; Collaborative approach

Outcome Measures

Primary Outcomes (1)

• HbA1c

  3 months

Secondary Outcomes (7)

• Lipid profile

  3 months

• Fasting blood glucose

  each month for 3 months

• Patients knowledge about their medications

  3 months

• Cost avoidance of implemented clinical pharmacist interventions

  3 months

• Patients adherence to medications

  3 months

Study Arms (2)

the intervention group

OTHER

this group received the collaborative care between the clinical pharmacist and physicians in a medical center

Other: Collaborative approach of clinical pharmacist with physicians in a medical center

the control group

NO INTERVENTION

this group received the standard care of physicians in a medical center without clinical pharmacist interventions

Interventions

Collaborative approach of clinical pharmacist with physicians in a medical center OTHER

For those who allocated to the intervention group, the clinical pharmacist interviewed them at each monthly visit about 30 minutes before seeing physicians, the clinical pharmacist identified treatment related problems, provided medication counseling, answered questions asked by patients or physicians, encouraged compliance, offered instructions on self-monitoring of blood pressure and glucose levels, distributed educational materials about diabetes and emphasis was made on optimizing adherence to pharmacological and non- pharmacological therapy. the pharmacist interventions on treatment related problems (TRPs) and proposed patient care plans were discussed with treatng physicians who decided to accept or reject them.

the intervention group

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• type 2 diabetic patients who aged 18 years or more with a HbA1c reading 6.5 % or more at the time of diagnosis

You may not qualify if:

• pregnant patients
• breastfeeding patients
• patients with urgent or emergent cases
• patients with cognitive impairment
• if the patient is unable to provide informed written consent

Sponsors & Collaborators

• University of Jordan: lead

Study Sites (1)

Abu-Nsair medical center

Amman, Jordan

Location

MeSH Terms

Interventions

Physicians

Intervention Hierarchy (Ancestors)

Health Personnel; Health Care Facilities Workforce and Services

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Purpose: OTHER
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Master student at the University of Jordan

Study Record Dates

• First Submitted: September 1, 2023
• First Posted: September 8, 2023
• Study Start: October 17, 2022
• Primary Completion: April 24, 2023
• Study Completion: April 24, 2023
• Last Updated: November 21, 2024

Record last verified: 2024-10

Data Sharing

• IPD Sharing: Will share

Locations

JO (1)